| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |